GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kangstem Biotech Co Ltd (XKRX:217730) » Definitions » Additional Paid-In Capital

Kangstem Biotech Co (XKRX:217730) Additional Paid-In Capital : ₩174,869 Mil(As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Kangstem Biotech Co Additional Paid-In Capital?


Kangstem Biotech Co's quarterly additional paid-in capital stayed the same from Sep. 2024 (₩174,869 Mil) to Dec. 2024 (₩174,869 Mil) and stayed the same from Dec. 2024 (₩174,869 Mil) to Mar. 2025 (₩174,869 Mil).

Kangstem Biotech Co's annual additional paid-in capital increased from Dec. 2022 (₩163,374 Mil) to Dec. 2023 (₩174,895 Mil) but then declined from Dec. 2023 (₩174,895 Mil) to Dec. 2024 (₩174,869 Mil).


Kangstem Biotech Co Additional Paid-In Capital Historical Data

The historical data trend for Kangstem Biotech Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangstem Biotech Co Additional Paid-In Capital Chart

Kangstem Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 131,311.37 163,373.53 163,373.73 174,894.55 174,869.36

Kangstem Biotech Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 174,894.55 174,869.36 174,869.36 174,869.36 174,869.36

Kangstem Biotech Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Kangstem Biotech Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Kangstem Biotech Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Kangstem Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
512 Teheran-ro, Gangnam-gu, 17th Floor, Sinan Building, Seoul, KOR
Kangstem Biotech Co Ltd develops technology to isolate the non-hematological system stem cell with conversion and purity from the cord blood and to culture large quantity. Its Furestem therapies include Furestem-AD, Furestem-RA and Furestem-CD. Its businesses include cord blood-derived stem cell therapy business; cord blood-derived stem cell conditioned media business; and stem cell culture media business.

Kangstem Biotech Co Headlines

No Headlines